Cerasela Jardan

Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases

Letiția-Elena Radu, Andrei Coliţă, Sergiu Paşca et al. · Frontiers in Oncology · 2020 · 23 citations · Full text

Medicine, Oncology, Pediatrics +16

The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia.

Crisan Am, Daniel Coriu, C Arion et al. · PubMed · 2016 · 18 citations · Full text

Medicine, Hematology, Pharmacology +17

The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression - an overlapping myeloproliferative disorder or two distinct diseases? - case report.

Iulia Ursuleac, Ac Colita, Tomáš Adam et al. · PubMed · 2013 · 16 citations · Full text

Medicine, Hematology, Molecular Genetics +17